Clinical Trial Update: Effects of Pioglitazone, a PPARgamma Receptor Agonist, on the Abuse Liability of Oxycodone [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether pioglitazone affects the abuse liability of oxycodone in individuals with opioid use disorder; results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Actos (Pioglitazone)
• Oxycodone (oxycodone)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Opioid Abuse | Phase 2 | Status: COMPLETED | Results posted: 2016-02-23